Cargando…
A unique plasma microRNA profile defines type 2 diabetes progression
A major unmet medical need to better manage Type 2 Diabetes (T2D) is the accurate disease prediction in subjects who show glucose dysmetabolism, but are not yet diagnosed as diabetic. We investigated the possibility to predict/monitor the progression to T2D in these subjects by retrospectively quant...
Autores principales: | de Candia, Paola, Spinetti, Gaia, Specchia, Claudia, Sangalli, Elena, La Sala, Lucia, Uccellatore, Annachiara, Lupini, Silvia, Genovese, Stefano, Matarese, Giuseppe, Ceriello, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714331/ https://www.ncbi.nlm.nih.gov/pubmed/29200427 http://dx.doi.org/10.1371/journal.pone.0188980 |
Ejemplares similares
-
Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D
por: La Sala, Lucia, et al.
Publicado: (2019) -
Circulating MicroRNA-15a Associates With Retinal Damage in Patients With Early Stage Type 2 Diabetes
por: Sangalli, Elena, et al.
Publicado: (2020) -
Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists
por: Uccellatore, Annachiara, et al.
Publicado: (2015) -
One-hour plasma glucose combined with skin autofluorescence identifies subjects with pre-diabetes: the DIAPASON study
por: La Sala, Lucia, et al.
Publicado: (2020) -
Blood Co-Circulating Extracellular microRNAs and Immune Cell Subsets Associate with Type 1 Diabetes Severity
por: Garavelli, Silvia, et al.
Publicado: (2020)